rs11200638

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000648167.1(HTRA1):​c.154+2319G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 152,162 control chromosomes in the GnomAD database, including 4,399 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).

Frequency

Genomes: 𝑓 0.23 ( 4399 hom., cov: 34)

Consequence

HTRA1
ENST00000648167.1 intron

Scores

3

Clinical Significance

risk factor no assertion criteria provided O:1

Conservation

PhyloP100: -0.125

Publications

295 publications found
Variant links:
Genes affected
HTRA1 (HGNC:9476): (HtrA serine peptidase 1) This gene encodes a member of the trypsin family of serine proteases. This protein is a secreted enzyme that is proposed to regulate the availability of insulin-like growth factors (IGFs) by cleaving IGF-binding proteins. It has also been suggested to be a regulator of cell growth. Variations in the promoter region of this gene are the cause of susceptibility to age-related macular degeneration type 7. [provided by RefSeq, Jul 2008]
HTRA1 Gene-Disease associations (from GenCC):
  • CARASIL syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • genetic cerebral small vessel disease
    Inheritance: AD Classification: STRONG Submitted by: Franklin by Genoox
  • HTRA1-related autosomal dominant cerebral small vessel disease
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000648167.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000648167.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HTRA1
ENST00000648167.1
c.154+2319G>A
intron
N/AENSP00000498033.1A0A3B3IU24
HTRA1-AS1
ENST00000650300.1
n.356C>T
non_coding_transcript_exon
Exon 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.234
AC:
35620
AN:
152042
Hom.:
4389
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.234
Gnomad AMI
AF:
0.237
Gnomad AMR
AF:
0.229
Gnomad ASJ
AF:
0.208
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.315
Gnomad FIN
AF:
0.235
Gnomad MID
AF:
0.191
Gnomad NFE
AF:
0.217
Gnomad OTH
AF:
0.238
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.234
AC:
35666
AN:
152162
Hom.:
4399
Cov.:
34
AF XY:
0.237
AC XY:
17634
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.234
AC:
9738
AN:
41542
American (AMR)
AF:
0.230
AC:
3521
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
722
AN:
3468
East Asian (EAS)
AF:
0.424
AC:
2176
AN:
5130
South Asian (SAS)
AF:
0.316
AC:
1528
AN:
4832
European-Finnish (FIN)
AF:
0.235
AC:
2487
AN:
10596
Middle Eastern (MID)
AF:
0.202
AC:
59
AN:
292
European-Non Finnish (NFE)
AF:
0.217
AC:
14721
AN:
67968
Other (OTH)
AF:
0.235
AC:
498
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1484
2967
4451
5934
7418
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.222
Hom.:
4659
Bravo
AF:
0.236
Asia WGS
AF:
0.369
AC:
1277
AN:
3478

ClinVar

ClinVar submissions
Significance:risk factor
Revision:no assertion criteria provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Age related macular degeneration 7 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
6.4
DANN
Benign
0.87
PhyloP100
-0.13

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11200638;
hg19: chr10-124220544;
COSMIC: COSV64564929;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.